menu
    • menu

    Company profile for Kashiv BioSciences

    NEW Drugs in Dev: 7
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Since its establishment in 2011, Kashiv BioSciences has evolved into a premier, fully integrated biopharmaceutical company offering next-generation drug delivery technologies, biosimilars, and specialty biopharmaceutical products. Kashiv is built on patient-focused innovation and leverages its expertise in small and large molecules to develop a clinically differentiated pipeline of novel compounds and biosimilars with lead can...
    Since its establishment in 2011, Kashiv BioSciences has evolved into a premier, fully integrated biopharmaceutical company offering next-generation drug delivery technologies, biosimilars, and specialty biopharmaceutical products. Kashiv is built on patient-focused innovation and leverages its expertise in small and large molecules to develop a clinically differentiated pipeline of novel compounds and biosimilars with lead candidates in various therapeutic areas, including CNS, endocrinology, cancer, and several debilitating orphan diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kashiv BioSciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    995 US HWY 202/206 Bridgewater, NJ 08807
    Telephone
    Telephone
    908.895.1520
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kashivbiosciences.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/kashiv-pharma
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kashiv Biosciences, Intas Pharma Ink Exclusive Deal For Complex
    Kashiv Biosciences, Intas Pharma Ink Exclusive Deal For Complex

    09 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-09/kashiv-biosciences-and-intas-pharmaceuticals-sign-an-exclusive-licensing-and-supply-agreement-for-co

    PHARMIWEB
    09 Feb 2026
    Share Share
    Kashiv Biosciences To Present At J.P. Morgan Healthcare Conf
    Kashiv Biosciences To Present At J.P. Morgan Healthcare Conf

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105670990/en/Kashiv-BioSciences-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Kashiv Biosecures Rs. 684 Crore To Expand Biopharma Facility
    Kashiv Biosecures Rs. 684 Crore To Expand Biopharma Facility

    26 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/biopharma/kashiv-biosciences-secures-rs-684-crore-funding-to-build-one-of-indias-largest-biopharma-facilities-18683

    INDPHARMAPOST
    26 Dec 2025
    Share Share
    Kashiv Submits BLA To FDA, EMA Accepts ADL-018 Xolair Biosimilar
    Kashiv Submits BLA To FDA, EMA Accepts ADL-018 Xolair Biosimilar

    06 Oct 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-10-06/kashiv-biosciences-announces-submission-of-biologics-license-application-to-us-fda-and-acceptance

    PHARMAWEB
    06 Oct 2025
    Share Share
    Kashiv Biosciences & JAMP Pharma Launch Pexegra & Filra in Canada
    Kashiv Biosciences & JAMP Pharma Launch Pexegra & Filra in Canada

    24 Sep 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-09-24/kashiv-biosciences-and-jamp-pharma-corporation-announce-the-launch-of-pexegra-and-filra-biosimilar

    PHARMIWEB
    24 Sep 2025
    Share Share
    Kashiv Bio, CRISTÁLIA License Omalizumab Biosimilar ADL-018
    Kashiv Bio, CRISTÁLIA License Omalizumab Biosimilar ADL-018

    11 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-11/kashiv-biosciences-and-cristália-enter-into-licensing-and-supply-agreement-for-omalizumab-biosimilar

    PHARMAWEB
    11 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search